SYN-TECH Chem. & Pharm Balance Sheet Health
Financial Health criteria checks 6/6
SYN-TECH Chem. & Pharm has a total shareholder equity of NT$2.3B and total debt of NT$260.0M, which brings its debt-to-equity ratio to 11.2%. Its total assets and total liabilities are NT$2.9B and NT$583.5M respectively. SYN-TECH Chem. & Pharm's EBIT is NT$281.9M making its interest coverage ratio -11.7. It has cash and short-term investments of NT$666.9M.
Key information
11.2%
Debt to equity ratio
NT$260.00m
Debt
| Interest coverage ratio | -11.7x |
| Cash | NT$666.92m |
| Equity | NT$2.32b |
| Total liabilities | NT$583.48m |
| Total assets | NT$2.90b |
Recent financial health updates
SYN-TECH Chem. & Pharm (GTSM:1777) Could Easily Take On More Debt
Mar 19
SYN-TECH Chem. & Pharm (GTSM:1777) Seems To Use Debt Rather Sparingly
Dec 19Recent updates
SYN-TECH Chem. & Pharm (GTSM:1777) Could Easily Take On More Debt
Mar 19Here's What You Should Know About SYN-TECH Chem. & Pharm. Co., Ltd.'s (GTSM:1777) 4.6% Dividend Yield
Feb 26Declining Stock and Decent Financials: Is The Market Wrong About SYN-TECH Chem. & Pharm. Co., Ltd. (GTSM:1777)?
Feb 05
SYN-TECH Chem. & Pharm's (GTSM:1777) Shareholders Are Down 11% On Their Shares
Jan 10SYN-TECH Chem. & Pharm (GTSM:1777) Seems To Use Debt Rather Sparingly
Dec 19Here's What You Should Know About SYN-TECH Chem. & Pharm. Co., Ltd.'s (GTSM:1777) 4.6% Dividend Yield
Nov 28Financial Position Analysis
Short Term Liabilities: 1777's short term assets (NT$1.4B) exceed its short term liabilities (NT$507.0M).
Long Term Liabilities: 1777's short term assets (NT$1.4B) exceed its long term liabilities (NT$76.5M).
Debt to Equity History and Analysis
Debt Level: 1777 has more cash than its total debt.
Reducing Debt: 1777's debt to equity ratio has reduced from 47.1% to 11.2% over the past 5 years.
Debt Coverage: 1777's debt is well covered by operating cash flow (100.9%).
Interest Coverage: 1777 earns more interest than it pays, so coverage of interest payments is not a concern.